On January 8, SSY GROUP announced on the Hong Kong Stock Exchange that it has obtained the Pharmaceutical production registration approval from the National Medical Products Administration of China for Fumaric Acid Vonoprazan Tablets (20mg and 10mg), which belong to Class 4 Chemical Drugs, considered to have passed the consistency evaluation. Fumaric Acid Vonoprazan Tablets are mainly used for the treatment of reflux esophagitis.
石四药集团：富马酸伏诺拉生片（20mg及10mg）获药品生产注册批件
SSY GROUP: Fumaric Acid Vonoprazan Tablets (20mg and 10mg) have received the Pharmaceutical production registration approval.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Investment Course
Choose stocks based on financial reports
Quickly master financial season learning guidelines
When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
In 【2024.11】, surged more than 0.04 million times, achieving the title of stock god Buffett! How do you view Berkshire's performance?
When it comes to legendary figures in the investment world, the name of Warren Buffett, the helm of Berkshire Hathaway, is definitely unavoidable. $Berkshire Ha
【November 2024】Has disney's predicament turned around? Pay attention to these 3 performance signals.
As the entertainment kingdom for nearly a century, Disney's status in Hollywood has gained prominence. Over 60 years of listing on the U.S. stock market, Disney